- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
BCL-6 corepressor antibody, also known as BCOR antibody, recognizes BCL-6 corepressor, a nuclear transcriptional regulatory protein encoded by the BCOR gene. BCL-6 corepressor is widely referred to as BCOR in the literature and functions predominantly within the nucleus where it participates in chromatin remodeling and transcriptional repression. It was originally identified through its interaction with the BCL6 transcription factor and is now known to serve as a critical epigenetic regulator across multiple developmental and oncogenic pathways.
BCOR is a defining component of the non-canonical polycomb repressive complex 1.1, where it cooperates with additional polycomb group proteins to mediate histone ubiquitination and stable gene silencing. Through these mechanisms, BCL-6 corepressor regulates genes involved in cell cycle control, differentiation, stem cell maintenance, and lineage commitment. Its activity is especially important during embryonic development, hematopoietic differentiation, and mesenchymal lineage specification. By recruiting epigenetic modifiers to target promoters, BCOR helps maintain transcriptional repression programs necessary for controlled tissue development and cellular identity.
Expression of BCOR has been observed in proliferating tissues and in cells undergoing developmental transitions. Alterations in the BCOR gene, including mutations, internal tandem duplications, and gene fusions, have been identified in a range of malignancies such as acute myeloid leukemia, clear cell sarcoma of the kidney, high grade endometrial stromal sarcoma, and other soft tissue tumors. Germline mutations in BCOR are associated with oculofaciocardiodental syndrome, underscoring its importance in craniofacial and cardiac development. Because of its involvement in epigenetic control and tumorigenesis, BCL-6 corepressor antibody is frequently used to investigate nuclear expression patterns in both developmental biology and cancer research settings.
BCL-6 corepressor antibody enables detection of nuclear BCOR protein in formalin-fixed tissues and cell lysates for research applications. Its nuclear staining pattern supports evaluation of transcriptional repression activity and aids in the study of tumors characterized by BCOR genetic alterations. Analysis of BCL-6 corepressor expression contributes to a deeper understanding of polycomb complex function and epigenetic dysregulation in human disease.
Optimal dilution of the BCL-6 corepressor antibody should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 100-400) from the human protein was used as the immunogen for the BCL-6 corepressor antibody.
Aliquot the BCL-6 corepressor antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.